Clinical trial

A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®

NCT01705236

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-20

PhasePHASE4

Study timeline

Study start (actual)2012-08-20Date precision: day

Registry last updated2020-03-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Remitting Multiple Sclerosis RRMSunresolved

Interventions

FingolimodDRUG · verified · RxNorm: fingolimod

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

DresdenGermany1 LeipzigGermany1 HanoverGermany1 HeidelbergGermany1 ZurichSwitzerland1 UlmGermany1 DüsseldorfGermany1 BonnGermany1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01705236 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.